Evidence map›Paper›PMID 42694699›Full record

ReviewThe Lancet regional health. Western Pacific2026

Infection-driven cancers in Asia: implications from epidemiological transitions.

Yingsong Lin, Manami Inoue

Abstract readReview
In one paragraph

Review in The Lancet regional health. Western Pacific, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Yingsong LinDepartment of Public Health, Aichi Medical University School of Medicine, Aichi, Japan.
Manami InoueGraduate School of Public Health, St. Luke's International University, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gastric, liver, and cervical cancers account for a disproportionate share of the global cancer burden, particularly in Asia, where infection-related cancers remain a major public health challenge. This narrative review aims to provide an overview of the epidemiological transition of these cancers and their implications for cancer control in Asia. Updated population-attributable fractions and other epidemiological evidence indicate a declining contribution of infections to overall cancer incidence, reflecting ongoing epidemiological transitions. While prevention of infection-driven cancers in Asia requires pathogen-specific strategies, they should be adapted to the changing epidemiological patterns. Population-wide

Indexed as

AsiaCancerInfectious agentsPopulation attributable fractionScreeningVaccine

Identifiers

PMID42694699
PMCPMC13540655

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.